BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

PPI-461: Preliminary Phase Ib data

Preliminary data from a double-blind, placebo-controlled, international Phase Ib trial in 16 treatment-naïve patients with chronic HCV genotype 1 infection showed that once-daily 50 and 100 mg doses of PPI-461 for 3 days were well...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >